David Weill

Publication Details

  • Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.

    Valentine VG, Weill D, Gupta MR, Raper B, Laplace SG, Lombard GA, Bonvillain RW, Taylor DE, Dhillon GS. J Heart Lung Transplant. 2008; 27 (8): 875-81

    Universal ganciclovir (GCV) prophylaxis is a strategy aimed at reducing cytomegalovirus (CMV) infection and delaying the development of bronchiolitis obliterans syndrome (BOS). However, the optimal duration of GCV prophylaxis remains unclear. We report our experience with GCV prophylaxis administered indefinitely and its effect on CMV pneumonitis, BOS and survival after lung transplantation (LT).

    PubMedID: 18656801

Stanford Medicine Resources:

Footer Links: